/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

PEPGEN INC. Share Price Today: Live Updates & Key Insights

PEPGEN INC. share price today is $4.7, up -1.47%. The stock opened at $4.6 against the previous close of $4.77, with an intraday high of $4.84 and low of $4.5.

PEPGEN INC. Share Price Chart

style
pb-0

PEPGEN INC.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

PEPGEN INC. Share Price Performance

$4.7 -0.0147(-1.47%) PEPG at 23 Mar 2026 02:43 PM Biotechnology
Lowest Today 4.5
Highest Today 4.84
Today’s Open 4.6
Prev. Close 4.77
52 Week High 7.80
52 Week Low 0.88
Day’s Range: Low 4.5 High 4.84
52-Week Range: Low 0.88 High 7.80
1 day return -
1 Week return -11.62
1 month return -25.27
3 month return -13.32
6 month return +117.78
1 year return +178.17
3 year return -72.44
5 year return -
10 year return -

PEPGEN INC. Institutional Holdings

RA Capital Management, LLC 29.03

Viking Global Investors LP 5.04

COMMODORE CAPITAL LP 4.92

Vivo Capital, LLC 3.36

Vanguard Group Inc 3.20

Point72 Asset Management, L.P. 2.94

Bvf Inc 2.77

LAURION CAPITAL MANAGEMENT LP 2.74

Nantahala Capital Management, LLC 2.24

HHG PLC 2.17

Vanguard Total Stock Mkt Idx Inv 2.04

Pictet Asset Manangement SA 1.96

Woodline Partners LP 1.90

Awm Investment Company Inc 1.88

Deep Track Capital, LP 1.74

TCG Crossover Management, LLC 1.74

Balyasny Asset Management LLC 1.25

Pictet-Biotech P USD 1.22

Perceptive Advisors LLC 1.20

Logos Global Management LP 1.09

Octagon Capital Advisors LP 1.01

Siren, L.L.C. 1.01

Vanguard Institutional Extnd Mkt Idx Tr 0.69

iShares Biotechnology ETF 0.64

Pictet-Global Megatrend Sel I USD 0.53

Fidelity Extended Market Index 0.34

Blackrock Extended Mkt Fund CF 0.17

iShares Micro-Cap ETF 0.17

Extended Equity Market Fund K 0.15

Fidelity Total Market Index 0.13

Nomura World Genome Tech Open Mother 0.13

Fidelity Series Total Market Index 0.11

Private Suite PICTET Hth In Td G EUR Acc 0.10

DFA US Small Cap I 0.10

Spartan Extended Market Index Pool F 0.09

NT Ext Equity Mkt Idx Fd - L 0.07

Bridgeway Ultra-Small Company Market 0.07

NT Ext Equity Mkt Idx Fd - NL 0.07

iShares Nasdaq US Biotech ETF USD Acc 0.07

Fidelity Nasdaq Composite Index 0.06

PEPGEN INC. Market Status

Strong Buy: 3

Buy: 1

Hold: 0

Sell: 1

Strong Sell: 0

PEPGEN INC. Fundamentals

Market Cap 324.84 M

PB Ratio 2.2125

PE Ratio 0.0

Enterprise Value 194.77 M

Total Assets 173.91 M

Volume 653776

PEPGEN INC. Company Financials

Annual Revenue FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M

Annual Profit FY24:null 0.0M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M

Annual Net worth FY24:-89981000 -90.0M, FY23:-74067000 -74.1M, FY22:-69104000 -69.1M, FY21:-27281000 -27.3M, FY20:-1881000 -1.9M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q4/2024:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q3/2025:-339000 -0.3M, Q2/2025:-334000 -0.3M, Q1/2025:-388000 -0.4M, Q4/2024:null 0.0M, Q3/2024:null 0.0M

Quarterly Net worth Q3/2025:-18026000 -18.0M, Q2/2025:-23087000 -23.1M, Q1/2025:-30202000 -30.2M, Q4/2024:-22242000 -22.2M, Q3/2024:-21384000 -21.4M

About PEPGEN INC. & investment objective

Company Information PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.

Organisation Biotechnology

Employees 56

Industry Biotechnology

CEO Dr. James G. McArthur Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

PEPGEN INC. FAQs

What is the share price of PEPGEN INC. today?

The current share price of PEPGEN INC. is $4.7.

Can I buy PEPGEN INC. shares in India?

Yes, Indian investors can buy PEPGEN INC. shares by opening an international trading and demat account with Motilal Oswal.

How to buy PEPGEN INC. shares in India?

You can easily invest in PEPGEN INC. shares from India by:

Can I buy fractional shares of PEPGEN INC.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of PEPGEN INC.?

PEPGEN INC. has a market cap of $324.84 M.

In which sector does PEPGEN INC. belong?

PEPGEN INC. operates in the Biotechnology sector.

What documents are required to invest in PEPGEN INC. stocks?

To invest, you typically need:

What is the PE and PB ratio of PEPGEN INC.?

The PE ratio of PEPGEN INC. is N/A and the PB ratio is 2.21.